申请人:Sterling Drug Inc.
公开号:US04009170A1
公开(公告)日:1977-02-22
1-(2-Substituted-hydrazino)-3,4-dihydroisoquinolines, prepared in one process by alkylating the corresponding 3,4-dihydroisocarbostyrils, hydrazinolyzing the resulting 1-alkoxy-3,4-dihydroisoquinolines and condensing the resulting 1-hydrazIno-3,4-dihydroisoquinolines with aldehydes or ketones, and 1,1'-azinobis(1,2,3,4-tetrahydroisoquinolines), prepared by condensing corresponding 1-alkoxy-3,4-dihydroisoquinolines and 1-hydrazino-3,4-dihydroisoquinolines, are useful as antihypertensive agents and/or as antiinflammatory agents.
1-(2-取代基-
肼基)-
3,4-二氢异喹啉,通过烷基化相应的
3,4-二氢异喹啉,
水解得到的1-烷氧基-
3,4-二氢异喹啉,以及与醛或酮缩合得到的1-
肼基-
3,4-二氢异喹啉,在一个过程中制备,以及通过缩合相应的1-烷氧基-
3,4-二氢异喹啉和1-
肼基-
3,4-二氢异喹啉制备的1,1'-
叠氮基(1,2,3,4-
四氢异喹啉),可用作降压剂和/或抗炎剂。